Adherium logo

ADR - Adherium Share Price

A$0.026 -0.0  -13.3%

Last Trade - 13/09/19

Sector
Healthcare
Size
Micro Cap
Market Cap £2.52m
Enterprise Value £244k
Revenue £2.45m
Position in Universe 1607th / 1858
Bullish
Bearish
Unlock ADR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ADR Revenue Unlock ADR Revenue

Net Income

ADR Net Income Unlock ADR Revenue

Normalised EPS

ADR Normalised EPS Unlock ADR Revenue

PE Ratio Range

ADR PE Ratio Range Unlock ADR Revenue

Dividend Yield Range

ADR Dividend Yield Range Unlock ADR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ADR EPS Forecasts Unlock ADR Revenue
Profile Summary

Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.

Directors
Last Annual June 30th, 2018
Last Interim December 31st, 2018
Incorporated April 17, 2015
Public Since August 26, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 174,273,932
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ADR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ADR
Upcoming Events for ADR
Similar to ADR
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.